Loading...
XKRX
214370
Market cap385mUSD
Jul 10, Last price  
61,100.00KRW
1D
3.38%
1Q
-28.62%
Jan 2017
-25.58%
IPO
-47.60%
Name

Caregen Co Ltd

Chart & Performance

D1W1MN
XKRX:214370 chart
P/E
29.87
P/S
8.25
EPS
2,045.27
Div Yield, %
0.41%
Shrs. gr., 5y
-0.15%
Rev. gr., 5y
3.84%
Revenues
72.81b
-11.84%
64,698,623,00060,295,113,00059,087,883,00069,097,674,88079,209,512,00082,585,948,00072,807,993,000
Net income
20.10b
-37.80%
28,069,502,00031,478,428,00025,318,235,00027,266,928,43039,929,881,00032,313,654,00020,098,550,000
CFO
18.59b
+37.84%
69,659,447,00030,775,990,00051,858,505,060-27,680,623,00028,602,567,00013,486,612,00018,589,459,000
Dividend
Jun 27, 2025240 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Caregen Co., Ltd. is primarily involved in the creation and development of biomimetic peptides. The company operates through distinct business segments, each catering to specific markets. Its Professional Therapy division engineers medical devices utilizing functional peptides and sophisticated sustained-release technology. Through its Cosmeceutical line, Caregen offers a variety of products for skin and hair care, including solutions for whitening, anti-inflammatory purposes, and those mimicking botulinum toxin functions. The Health Functional Food division provides dietary supplements specifically designed for blood control. Additionally, the Raw Material segment supplies essential peptide growth factors. Founded on August 17, 2001, the firm is headquartered in Anyang-si, South Korea.
IPO date
Nov 17, 2015
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT